Rate My Professor Anthony Gill
.webp){kind=logo}
Ratings & reviews
Helps students build confidence and skills.
Helps students see the joy in learning.
Always positive, enthusiastic, and supportive.
Inspires students to reach new heights.
Great Professor!
Taught by or worked with Anthony?
Add your rating. It takes about 30 seconds.
About Anthony
Professor Anthony Gill AM, MBBS MD FRCPA, serves as Professor of Surgical Pathology in the Northern Clinical School of the Faculty of Medicine and Health at the University of Sydney. He is a senior staff specialist in anatomical pathology at Royal North Shore Hospital, a position he has held since January 2005. Since January 2012, Professor Gill has led the Cancer Diagnosis and Pathology Research Group at the Kolling Institute of Medical Research and chairs the Australian Pancreatic Cancer Genome Initiative. His academic and research interests center on surgical pathology, including hereditary cancer syndromes, endocrine pathology, molecular pathology of cancer, cancer diagnosis, cell biology, and tumor histopathology. Professor Gill is noted for establishing diagnostic criteria for tumours that are applied internationally. He also leads clinical pathology teaching at the University of Sydney, contributing significantly to medical education.
Professor Gill's research has produced high-impact publications, such as co-authorship on "Signatures of mutational processes in human cancer" (Nature, 2013; over 11,000 citations), "The immune landscape of cancer" (Immunity, 2018; nearly 6,000 citations), "The 2016 WHO classification of tumours of the urinary system and male genital organs" (over 5,000 citations), "The 2019 WHO classification of tumours of the digestive system" (over 4,000 citations), and "Genomic analyses identify molecular subtypes of pancreatic cancer" (Nature, 2016; over 4,000 citations). Recent works include studies on symptom phenotypes in small-bowel neuroendocrine tumours (2026), adjuvant chemotherapy for intraductal papillary mucinous neoplasms (2026), and updates to WHO classifications of genetic tumour syndromes and digestive system tumours. His contributions have earned prestigious honors, including the Member of the Order of Australia (AM), the 2023 NSW Premier's Award for Outstanding Cancer Researcher of the Year, the Distinguished Pathologist Award (2022), and recognition as a world-leading researcher in pathology by The Australian (2024). Professor Gill's work profoundly influences global cancer pathology standards and diagnostics.
Trending Research & Publication News
SPARC Cost of Knowledge Study: 95% Public Investment in Articles
Photo by Precondo CA on Unsplash
AI Research Scooping: OpenAI & Anthropic Priority Disputes
Photo by Brecht Corbeel on Unsplash
Informa Taylor & Francis Split & Clarion Deal | AcademicJobs
Photo by Anne Nygård on Unsplash
arXiv Two-Submission Monthly Cap Explained | AcademicJobs
Photo by Kelly Sikkema on Unsplash
Cell Press Bribery Investigation: Cancer Cell Editor Accused
Photo by Markus Winkler on Unsplash
Society Journal Sales & Nonprofit Consolidations | AcademicJobs
Photo by Philip Strong on Unsplash